Publications

Filters

Publications Atlas Journal Article Research Report

Clinical and Practice Brain diseases Cancer and cancer screening Cardiovascular disease Chronic diseases and multimorbidity Diet and nutrition Endocrinology Environmental health Eye, ear, nose and throat disorders Gastroenterology Hematology Infectious diseases Injuries and accidents Internal medicine Kidney disease Lung health Musculoskeletal diseases and disorders Organ transplantation and donation Pharmacoepidemiology and drug safety Reproductive medicine Skin diseases and disorders

Healthcare Providers and Services Acute and emergency services End-of-life care Home and community care Long-term care and continuing care Maternity and neonatal care Mental health and addictions Nursing Pediatrics Pharmacy Primary care Public health Rehabilitation Surgery

People and Society Children and young people Health and healthcare inequality Indigenous Peoples Marginalized populations Older people Racialized communities Women or gender-based research

Research and Methods Data science Decision science Epidemiology Health economics Health services research Implementation science and knowledge translation Policy and program evaluation Statistics Trials

From

ICES Central ICES McMaster ICES North ICES Queen's ICES UofT ICES uOttawa ICES Western

Cancer Cardiovascular Chronic Disease & Pharmacotherapy Kidney, Dialysis & Transplantation Life Stage Mental Health & Addictions Populations & Public Health Primary Care & Health Systems

Showing 1-10 of 315

Journal Article

26/04/2022

Risk of suicide death following electroconvulsive therapy treatment for depression: a propensity score-weighted, retrospective cohort study in Canada

Kaster TS, Blumberger DM, Gomes T, Sutradhar R, Wijeysundera DN, Vigod SN. Lancet Psychiatry. 2022; 9(6):435-46. Epub 2022 Apr 26.

Journal Article

26/04/2022

Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study

Antoniou T, Men S, Tadrous M, Leece P, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109473. Epub 2022 Apr 26.

Journal Article

14/04/2022

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis

Garg R, Kitchen SA, Men S, Campbell TJ, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Drug Alcohol Depend. 2022; 236:109459. Epub 2022 Apr 14.

Journal Article

13/04/2022

Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions

Bouck Z, Scheimac AI, Gomes T, Ling V, Caudarella A, Werb D. Int J Drug Policy. 2022; 104:103680. Epub 2022 Apr 13.

Journal Article

01/04/2022

Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: a cross-sectional study

Konstantelos N, Shakeri A, McCormack D, Campos-Meade A, Gomes T, Murti M, Pierre-Pierre V, Tadrous M. Can Commun Dis Rep. 2022; 48(4):170-8. Epub 2022 Apr 1.

Journal Article

11/03/2022

The risk of ventricular dysrhythmia or sudden death in patients receiving serotonin reuptake inhibitors with methadone: a population-based study

Antoniou T, McCormack D, Tadrous M, Juurlink DN, Gomes T. Front Pharmacol. 2022; 13:861953. Epub 2022 Mar 11.

Journal Article

08/03/2022

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study

Gomes T, McCormack D, Bozinoff N, Tadrous M, Antoniou T, Munro C, Campbell T, Paterson JM, Mamdani M, Sproule B. Addiction. 2022; 117(7):1972-81. Epub 2022 Mar 8.

Journal Article

01/03/2022

Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation

Gomes T, Campbell TJ, Kitchen SA, Garg R, Bozinoff N, Men S, Tadrous M, Munro C, Antoniou T, Werb D, Wyman J. JAMA. 2022; 327(9):846-55. Epub 2022 Mar 1.

Journal Article

01/03/2022

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis

Kitchen SA, Campbell TJ, Men S, Bozinoff N, Tadrous M, Antoniou T, Wyman J, Werb D, Munro C, Gomes T. Int J Drug Policy. 2022; 103:103644. Epub 2022 Mar 1.

Journal Article

23/02/2022

Evaluation of definitions for oral anticoagulant-associated major bleeding: a population-based cohort study

Xu Y, Gomes T, Wells PS, Pequeno P, Johnson A, Sholzberg M. Thromb Res. 2022; 213:57-64. Epub 2022 Feb 23.

« Previous 1 … 8 9 10 11 12 … 32 Next »

Publications

Filters

Resource Type

Topic

Date

ICES Scientists

ICES Site

Research Program

Risk of suicide death following electroconvulsive therapy treatment for depression: a propensity score-weighted, retrospective cohort study in Canada

Impact of a publicly funded pharmacy-dispensed naloxone program on fatal opioid overdose rates: a population-based study

Impact of the COVID-19 pandemic on the prevalence of opioid agonist therapy discontinuation in Ontario, Canada: a population-based time series analysis

Evaluating interventions to facilitate opioid agonist treatment access among people who inject drugs in Toronto, Ontario during COVID-19 pandemic restrictions

Regional differences in access to direct-acting antiviral treatments for hepatitis C across Ontario: a cross-sectional study

The risk of ventricular dysrhythmia or sudden death in patients receiving serotonin reuptake inhibitors with methadone: a population-based study

Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population-based propensity-score matched cohort study

Association between increased dispensing of opioid agonist therapy take-home doses and opioid overdose and treatment interruption and discontinuation

Impact of the COVID-19 pandemic on the provision of take-home doses of opioid agonist therapy in Ontario, Canada: a population-based time-series analysis

Evaluation of definitions for oral anticoagulant-associated major bleeding: a population-based cohort study